Notice
This is not the latest version of this item. The latest version can be found at:https://dspace.mit.edu/handle/1721.1/136560.2
From Molecule to Patient: A Biotech Perspective
| dc.contributor.author | Langer, Robert | |
| dc.contributor.author | Jaklenec, Ana | |
| dc.contributor.author | Traverso, Giovanni | |
| dc.contributor.author | Hartman, Daniel | |
| dc.date.accessioned | 2021-10-27T20:35:58Z | |
| dc.date.available | 2021-10-27T20:35:58Z | |
| dc.date.issued | 2020 | |
| dc.identifier.uri | https://hdl.handle.net/1721.1/136560 | |
| dc.language.iso | en | |
| dc.publisher | Wiley | |
| dc.relation.isversionof | 10.1002/CPT.1676 | |
| dc.rights | Creative Commons Attribution 4.0 International license | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.source | Wiley | |
| dc.title | From Molecule to Patient: A Biotech Perspective | |
| dc.type | Article | |
| dc.relation.journal | Clinical Pharmacology and Therapeutics | |
| dc.eprint.version | Final published version | |
| dc.type.uri | http://purl.org/eprint/type/JournalArticle | |
| eprint.status | http://purl.org/eprint/status/PeerReviewed | |
| dc.date.updated | 2021-06-22T14:12:14Z | |
| dspace.orderedauthors | Langer, R; Jaklenec, A; Traverso, G; Hartman, D | |
| dspace.date.submission | 2021-06-22T14:12:17Z | |
| mit.journal.volume | 107 | |
| mit.journal.issue | 1 | |
| mit.license | PUBLISHER_CC | |
| mit.metadata.status | Authority Work and Publication Information Needed |
